IC

Ikarian Capital Portfolio holdings

AUM $699M
1-Year Est. Return 600.17%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+600.17%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$699M
AUM Growth
-$73.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
169
New
Increased
Reduced
Closed

Top Buys

1
+$30.3M
2
+$15.8M
3
+$14.1M
4
CLDX icon
Celldex Therapeutics
CLDX
+$12.6M
5
BBIO icon
BridgeBio Pharma
BBIO
+$11.6M

Top Sells

1
+$60.4M
2
+$25.8M
3
+$22.5M
4
ABVX
Abivax
ABVX
+$17.6M
5
AMGN icon
Amgen
AMGN
+$14.7M

Sector Composition

1 Healthcare 99.35%
2 Financials 0.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JSPR icon
126
Jasper Therapeutics
JSPR
$15.4M
$21.1K ﹤0.01%
24,093
AMIX
127
Autonomix Medical
AMIX
$4.69M
$7.29K ﹤0.01%
18,688
ADMA icon
128
ADMA Biologics
ADMA
$1.8B
– –
-234,854
AGIO icon
129
Agios Pharmaceuticals
AGIO
$1.58B
– –
-115,489
AMGN icon
130
Amgen
AMGN
$177B
– –
-45,000
ANEB
131
DELISTED
Anebulo Pharmaceuticals
ANEB
– –
-17,736
APLS
132
DELISTED
Apellis Pharmaceuticals
APLS
– –
-71,747
AQST icon
133
Aquestive Therapeutics
AQST
$493M
– –
0
ARWR icon
134
Arrowhead Research
ARWR
$9.98B
– –
0
AVTX icon
135
Avalo Therapeutics
AVTX
$734M
– –
-31,106
BMY icon
136
Bristol-Myers Squibb
BMY
$111B
– –
0
CDTX
137
DELISTED
Cidara Therapeutics
CDTX
– –
-273,243
CELC icon
138
Celcuity
CELC
$4.46B
– –
-105,545
CGON icon
139
CG Oncology
CGON
$4.8B
– –
-199,473
CORT icon
140
Corcept Therapeutics
CORT
$7.64B
– –
-185,593
CPRX icon
141
Catalyst Pharmaceutical
CPRX
$3.83B
– –
-57,388
CRNX icon
142
Crinetics Pharmaceuticals
CRNX
$3.44B
– –
0
CTMX icon
143
CytomX Therapeutics
CTMX
$688M
– –
-3,172,616
DXCM icon
144
DexCom
DXCM
$28.3B
– –
0
ELVN icon
145
Enliven Therapeutics
ELVN
$2.16B
– –
0
ERAS icon
146
Erasca
ERAS
$4.19B
– –
-735,396
EYPT icon
147
EyePoint Inc
EYPT
$1.05B
– –
0
GOSS icon
148
Gossamer Bio
GOSS
$44.2M
– –
0
GPCR icon
149
Structure Therapeutics
GPCR
$2.64B
– –
-4,824
IWM icon
150
iShares Russell 2000 ETF
IWM
$78.6B
– –
0
3 4 5
6
7